Susquehanna International Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.51M | Sell |
133,707
-127,351
| -49% | -$1.44M | ﹤0.01% | 2672 |
|
|
2025
Q1 | $2.63M | Buy |
261,058
+134,271
| +106% | +$1.35M | ﹤0.01% | 1927 |
|
|
2024
Q4 | $1.5M | Sell |
126,787
-183,220
| -59% | -$2.17M | ﹤0.01% | 2371 |
|
|
2024
Q3 | $3.58M | Buy |
310,007
+15,582
| +5% | +$180K | ﹤0.01% | 1345 |
|
|
2024
Q2 | $3.11M | Sell |
294,425
-309,637
| -51% | -$3.27M | ﹤0.01% | 1345 |
|
|
2024
Q1 | $6.37M | Buy |
+604,062
| New | +$6.37M | ﹤0.01% | 877 |
|
|
2023
Q4 | – | Sell |
-204,056
| Closed | -$2.38M | – | 6533 |
|
|
2023
Q3 | $2.38M | Buy |
204,056
+154,035
| +308% | +$1.8M | ﹤0.01% | 1684 |
|
|
2023
Q2 | $504K | Sell |
50,021
-171,346
| -77% | -$1.73M | ﹤0.01% | 3611 |
|
|
2023
Q1 | $1.63M | Buy |
221,367
+192,946
| +679% | +$1.42M | ﹤0.01% | 2213 |
|
|
2022
Q4 | $227K | Sell |
28,421
-13,992
| -33% | -$112K | ﹤0.01% | 4294 |
|
|
2022
Q3 | $137K | Buy |
42,413
+6,118
| +17% | +$19.8K | ﹤0.01% | 5085 |
|
|
2022
Q2 | $148K | Sell |
36,295
-172
| -0.5% | -$701 | ﹤0.01% | 4777 |
|
|
2022
Q1 | $180K | Buy |
36,467
+25,724
| +239% | +$127K | ﹤0.01% | 4895 |
|
|
2021
Q4 | $108K | Buy |
+10,743
| New | +$108K | ﹤0.01% | 5261 |
|